Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2
This study has been completed.
Sponsor:
BZL Biologics
Information provided by:
BZL Biologics
ClinicalTrials.gov Identifier:
NCT00040586
First received: July 1, 2002
Last updated: January 19, 2007
Last verified: July 2002
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |